CID 85261151

Myricatomentoside i

Structural Information

Molecular Formula
C26H32O10
SMILES
COC1=C2C=CC(=C1OC3C(C(C(C(O3)CO)O)O)O)CCCCC(=O)CCC4=CC(=C(C=C4)O)O2
InChI
InChI=1S/C26H32O10/c1-33-25-18-11-8-15(24(25)36-26-23(32)22(31)21(30)20(13-27)35-26)4-2-3-5-16(28)9-6-14-7-10-17(29)19(12-14)34-18/h7-8,10-12,20-23,26-27,29-32H,2-6,9,13H2,1H3
InChIKey
RALVCBWUWHJOGL-UHFFFAOYSA-N
Compound name
4-hydroxy-17-methoxy-16-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-10-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

504.19955 Da
Monoisotopic Mass

1.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 505.20683 222.3
[M+Na]+ 527.18877 219.2
[M-H]- 503.19227 206.1
[M+NH4]+ 522.23337 225.2
[M+K]+ 543.16271 222.9
[M+H-H2O]+ 487.19681 222.1
[M+HCOO]- 549.19775 212.0
[M+CH3COO]- 563.21340 220.5
[M+Na-2H]- 525.17422 226.4
[M]+ 504.19900 224.2
[M]- 504.20010 224.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.